Position in ZYME
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$953,351
+$30,001 QoQ
Shares Held
36,471
-1.1% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#92
of 202 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 50%
Shared 50%
None 0%
Common Shares in ZYME Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TUDOR INVESTMENT CORP ET AL holds $414,135,114 across 107 Biotechnology names. ZYME ranks #64 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
943,287 | $66,643,226 | |
| 2 | RPRX |
Royalty Pharma plc
|
610,736 | $34,243,967 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
545,387 | $32,919,559 | |
| 4 | ABVX |
Abivax S.A.
|
187,335 | $24,964,262 | |
| 5 | INSM |
INSMED Inc
|
195,391 | $20,832,588 | |
| 6 | MLYS |
Mineralys Therapeutics, Inc.
|
738,370 | $19,921,222 | |
| 7 | ABCL |
AbCellera Biologics Inc.
|
2,063,191 | $16,196,049 | |
| 8 | QURE |
uniQure N.V.
|
328,889 | $15,148,627 |
All Filings in ZYME
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $953,351 | 36,471 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $923,350 | 36,875 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $798,430 | 30,324 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $641,917 | 37,583 | Shares | Defined | 2025-12-09 | |
| 2025-06-30 | $430,377 | 34,293 | Shares | Defined | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||